COVID-19 community-based treatments

Please note this information is for clinicians only. If you have a patient enquiry regarding access to COVID treatments please contact your GP or call NHS 111. Further information for patients is available on the website.

Clinical Commissioning Policies

Title Date published/updated
Interim Clinical Commissioning Policy: Remdesivir and molnupiravir for non-hospitalised patients with COVID-19 11 May 2023
Commissioning Framework: COVID-19 therapeutics for non-hospitalised patients 22 December 2022
Interim Clinical Commissioning Policy: Treatments for non-hospitalised patients with COVID-19 28 November 2022

Information for clinicians and NHS managers

Title Date published/updated
Transition of COVID treatments to routine pathways 27 March 2023
Role of 111 teams in supporting patient access to treatments for COVID-19 28 February 2023
Fact sheet – Role of general practice teams in supporting patient access to COVID-19 treatments 9 January 2023
Cohorts eligible for community COVID-19 treatments who require contact by consultants 8 June 2022
Letter to clinicians: Contacting your patients about new COVID-19 treatments 8 June 2022
Letter to General Practices : Deployment of COVID-19 treatments for highest risk non-hospitalised patients 31 May 2022
Treatments for non-hospitalised patients at highest risk from COVID-19 infection aged 12 years and over: Update to supporting information for NHS111/IUC CAS service providers 9 February 2022
Assessment, monitoring and management of symptomatic COVID-19 patients in the community 6 January 2022
COVID Medicine Delivery Unit directory 3 February 2022

Patient facing information for clinicians

Title Date published/updated
Paxlovid antiviral medicine patient leaflet 4 May 2022
Molnupiravir patient information leaflet 4 May 2022
Letter to patients: Important information about new treatments for coronavirus 31 March 2022